deltatrials

Agency for Healthcare Research and Quality (AHRQ) Clinical Trials

Sponsors / Agency for Healthcare Research and Quality (AHRQ)

The ClinicalTrials.gov registry records 419 trials led by Agency for Healthcare Research and Quality (AHRQ). Across the portfolio, 34 are in recruitment, 16 are active non-recruiting, and 325 have reached completion. 7 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Across the portfolio, planned enrollment totals 6,761,134 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.

419
Total Trials
34
Recruiting
16
Other Active
325
Completed
7
Terminated / Withdrawn
6,761,134
Total Enrollment

Termination reasons: Recruitment43% · Other29% · Funding29%

Recent Terminations

  • NCT05063474 Stopped Apr 2023
    Peripheral Artery Disease
    "Poor enrollment and lack of funding"
  • NCT03982017 Phase NA Stopped Jul 2020
    Heart Failure
    "Patient enrollment was initially suspended due to COVID19 pandemic, then the study was closed due to institutional requirements for clinical trials."
  • NCT03783650 Phase NA Stopped Jul 2020
    Pediatric Hypertension
    "Study halted prematurely and will not resume due to the COVID-19 pandemic."
  • NCT03553732 Stopped Sep 2019
    Prostatic Neoplasms
    "Lack of funding"
  • NCT01362686 Phase NA Stopped Oct 2015
    Alzheimer's Disease
    "Low study accrual caused the study to be ended early."
  • NCT01717456 Phase NA Stopped Mar 2015
    Fecal Incontinence
    "Low enrollment led sponsor to terminate study early."
  • NCT00860249 Phase NA Stopped Dec 2009
    Colorectal Cancer
    "Lack of sufficient participants meeting the eligibility criteria to complete study in proposed and acceptable time frame."

Active Trials (16 total)

Top Conditions

Top Locations